Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Lucentis cleared in Europe for pathological myopia

Lucentis cleared in Europe for pathological myopia Makes Novartis' drug the first anti-VEGF approved in this setting. Novartis has been given a green light in the EU for the use of its Lucentis product in the treatment ... Specifically, Lucentis (ranibizumab) has been approved by the European Commission

Eylea set to challenge Lucentis in UK after NICE recommendation

Eylea set to challenge Lucentis in UK after NICE recommendation Novartis has seen its drug Lucentis (ranibizumab) become the standard-of-care in the country for wet AMD – the most common cause of blindness in the western world – after it was ... However, Eylea (aflibercept) today received final draft guidance

Novartis wins third NICE recommendation for Lucentis

Novartis wins third NICE recommendation for Lucentis This adds to a recommendation in February 2013 for the use of Lucentis to treat diabetes-related macular oedema and a 2008 recommendation to treat age-related macular degeneration. ... However, as with Lucentis' previous NICE recommendations, Novartis

NICE turns down Novartis’ blood cancer drug Jakavi

NICE turns down Novartis’ blood cancer drug Jakavi for several other products,  including Gilenya, Tasigna and Lucentis, that were subsequently given the green light.

Boehringer backs gene therapy firm Eyevensys

Boehringer backs gene therapy firm Eyevensys At the moment, the treatment for AMD relies on regular intraocular injections of drugs such as Novartis' Lucentis (ranibizumab) and Bayer's Eylea (aflibercept).

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics